Risks of postmenopausal hormone replacement [1] (multiple letters)

JAMA

Volumn 288, Issue 22, 2002, Pages 2819-2824

  Radford, Nina ^a   Church, Tim ^a   Speizer, Frank E ^b   Pearson Murphy, Beverley E ^c   Davis, Susan R ^d   Burger, Henry G ^d   Goodson III, William H ^e   Franke, Henk R ^f   Lev, Ishay ^g   Lahad, Amnon ^g   Karni, Aharon ^g   Brunner, Eric ^h   Gillon, Raanan ⁱ   Stokes, Houston H ^j   Garbe, Edeltraut ^k   Suissa, Samy ^c   Savitz, Sean I ^b   Caplan, Lou ^b  

^a Cooper Institute ^*  (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c MCGILL UNIVERSITY   (Canada)

^d Jean Hailes Foundation for Women's Health   (Australia)

^e California Pacific Medical Research Institute   (United States)

^f MEDISCH SPECTRUM TWENTE   (Netherlands)

^g HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^h UNIVERSITY COLLEGE LONDON   (United Kingdom)

ⁱ IMPERIAL COLLEGE LONDON   (United Kingdom)

^j UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^k HUMBOLDT UNIVERSITY   (Germany)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CONJUGATED ESTROGEN; ESTROGEN; GESTAGEN;

ATHEROSCLEROSIS; BREAST CANCER; COLON CANCER; DRUG EFFECT; DRUG MEGADOSE; FOLLOW UP; HIP FRACTURE; HORMONE SUBSTITUTION; HUMAN; ISCHEMIC HEART DISEASE; LETTER; LUNG EMBOLISM; MENOPAUSE; MORTALITY; OSTEOLYSIS; PLAQUE FORMING CELL; POSTMENOPAUSE; PRIORITY JOURNAL; RISK FACTOR; STATISTICAL ANALYSIS; STROKE; VEIN THROMBOSIS; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; ESTROGEN THERAPY; FEMALE; NOTE; RISK;

CORONARY ARTERIOSCLEROSIS; CORONARY DISEASE; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; POSTMENOPAUSE; RISK;

EID: 0037065330     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.288.22.2819     Document Type: Letter

References (0)